Cargando…
iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer
A major challenge in the management of patients with prostate cancer is identifying those individuals at risk of developing metastatic disease, as in most cases the disease will remain indolent. We analyzed pooled serum samples from 4 groups of patients (n = 5 samples/group), collected prospectively...
Autores principales: | Rehman, Ishtiaq, Evans, Caroline A., Glen, Adam, Cross, Simon S., Eaton, Colby L., Down, Jenny, Pesce, Giancarlo, Phillips, Joshua T., Yen, Ow Saw, Thalmann, George N., Wright, Phillip C., Hamdy, Freddie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280251/ https://www.ncbi.nlm.nih.gov/pubmed/22355332 http://dx.doi.org/10.1371/journal.pone.0030885 |
Ejemplares similares
-
Correction: iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer
por: Rehman, Ishtiaq, et al.
Publicado: (2012) -
iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance
por: Tonack, S, et al.
Publicado: (2013) -
Quantitative proteomic analysis by iTRAQ(® )for the identification of candidate biomarkers in ovarian cancer serum
por: Boylan, Kristin LM, et al.
Publicado: (2010) -
iTRAQ plasma proteomics analysis for candidate biomarkers of type 2 incipient diabetic nephropathy
por: Lu, Hongmei, et al.
Publicado: (2019) -
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005)